Relationship between body mass index and hippocampal glutamate/glutamine in bipolar disorder

David J. Bond, Leonardo Evangelista Da Silveira, Erin L. MacMillan, Ivan J. Torres, Donna J. Lang, Wayne Su, William G. Honer, Raymond W. Lam, Lakshmi N. Yatham

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Background We previously reported that patients with early-stage bipolar disorder, but not healthy comparison controls, had body mass index (BMI)-related volume reductions in limbic brain areas, suggesting that the structural brain changes characteristic of bipolar disorder were more pronounced with increased weight. Aims To determine whether the most consistently reported neurochemical abnormality in bipolar disorder, increased glutamate/glutamine (Glx), was also more prominent with higher BMI. Method We used single-voxel proton magnetic resonance spectroscopy to measure hippocampal Glx in 51 patients with first-episode mania (mean BMI = 24.1) and 28 healthy controls (mean BMI = 23.3). Results In patients, but not healthy controls, linear regression demonstrated that higher BMI predicted greater Glx. Factorial ANCOVA showed a significant BMI6diagnosis interaction, confirming a distinct effect of weight on Glx in patients. Conclusions Together with our volumetric studies, these results suggest that higher BMI is associated with more pronounced structural and neurochemical limbic brain changes in bipolar disorder, even in early-stage patients with low obesity rates.

Original languageEnglish (US)
Pages (from-to)146-152
Number of pages7
JournalBritish Journal of Psychiatry
Issue number2
StatePublished - Feb 2016

Bibliographical note

Publisher Copyright:
© The Royal College of Psychiatrists 2016.


Dive into the research topics of 'Relationship between body mass index and hippocampal glutamate/glutamine in bipolar disorder'. Together they form a unique fingerprint.

Cite this